Chief Executive Officer
Pearl Pathways
"Gretchen Miller Bowker is the founder of Pearl Pathways and Pearl IRB. She serves as Chief Executive Officer, overseeing the management team responsible for regulatory and QA services, clinical development and IRB services, business development, finance and all business operations. Gretchen has over 30 years of experience in the development of life science products and the regulatory approval process. She is recognized as a leader in the life science industry and one of only two fellows in the regulatory affairs professional society in the state of Indiana. Gretchen spent over 15 years of her career in large sponsor company environments working at both Eli Lilly and Roche Diagnostics (formerly Boehringer Mannheim). She also possesses real-world small startup experience, having led the regulatory, quality compliance and clinical teams at an oncology biotech startup. Throughout her career, she has successfully assembled teams of experts, developed processes and procedures, led global submissions, and implemented quality systems which ensured successful product development of drug, device and diagnostic products.
Prior to co-founding Pearl Pathways, Gretchen served as Director of Regulatory and Compliance Service Delivery at a Midwest consulting company where she served institutions, sponsors, and CROs. Gretchen is an experienced team leader with specific expertise in meeting global regulatory body compliance expectations for nonclinical, CMC, and clinical development throughout the product lifecycle.
Gretchen holds an M.S. in Biology from Purdue University, a B.S. in Biology from Indiana University, has been RAC certified since 2002, and is a RAPS fellow."
Disclosure information not submitted.
Sponsored Presentation: The top gotchas when expanding your clinical development into the US
Wednesday, May 8, 2024
13:15 – 13:45 CEST